top of page

PERSONALIZED CARTILAGE ANALYSIS

OptimateOA™: Arthritis-on-a-Chip

OptimateOA™ technology is based on the establishment of an array of fully functional healthy and diseased cartilage-like structures that mimic the onset and progression of osteoarthritis.  Additionally, multiple devices can be linked using tiny, fluid-filled channels to study how different cells respond to different drugs.

IMG_20201204_131509.jpg

OPTIMATE OA™

 Our innovative solution:

Our patented, CE marked and ISO 13485 certified in-vitro diagnostic organ-on-a-chip tool allows for gene expression
profiling based on qPCR testing of a patient’s own cells to identify individual responses to treatment
options in just 6 weeks.
Our solution offers a significantly faster, and more effective alternative to current diagnostic
standards, resulting in: (1) faster pain management (2) less frustration (3) better long-term
treatment outcomes (4) and ultimately, fewer joint replacement surgeries.
Beyond revolutionizing arthritis care, Optimate OA™

 will offer pharmaceutical companies
substantial savings as a sustainable alternative to animal testing, alongside unprecedented
patient stratification and data mining capabilities.


Disclaimer: outside of the CE IVD scope, shall be used for research use only and not for diagnostic.
Intended to be used by Healthcare Professionals and Laboratories. 

INSTRUCTIONS FOR USE - EN

INSTRUCTIONS FOR USE - DE

bottom of page